Patent Litigation and Generic Entry: Why Drug Disputes Delay Affordable Medicines
Martyn F. Jan. 9 14Patent litigation delays generic drug launches by years, even after FDA approval. Brand companies use legal tactics like serial patents and pay-for-delay deals to protect profits, costing patients billions and denying access to affordable medicines.
More Detail
Rhabdomyolysis from Medication Interactions: How Common Drug Combos Cause Muscle Breakdown
Martyn F. Jan. 8 14Rhabdomyolysis from medication interactions is a life-threatening muscle breakdown condition often triggered by common drug combos like statins and antibiotics. Know the signs, risks, and how to prevent it.
More Detail
Off-Label Drug Use: Why Doctors Prescribe Medications Beyond FDA Approval
Martyn F. Jan. 6 12Off-label drug use is legal and common, with up to 20% of prescriptions in the U.S. used for unapproved purposes. Learn why doctors prescribe medications beyond FDA labels, the risks involved, and how insurance and evidence shape this practice.
More Detail
Bariatric Surgery and Medication Absorption: How Dose and Formulation Changes Affect Your Pills
Martyn F. Jan. 5 15After bariatric surgery, many medications don't absorb properly due to changes in stomach acid, gut anatomy, and transit time. Learn which drugs are affected, how to adjust doses, and what new solutions are emerging in 2025.
More Detail
Are Generic Drugs Really Just as Good as Brand-Name Medications? The Truth Behind the Price Difference
Martyn F. Jan. 3 12Generic drugs contain the same active ingredients as brand-name medications and are held to the same FDA standards. They work just as well for most people and save billions annually. Here’s what you need to know before switching.
More Detail
Fluoroquinolones and Tendon Rupture: What You Need to Know About the Risks
Martyn F. Dec. 30 11Fluoroquinolone antibiotics like ciprofloxacin and levofloxacin carry a serious risk of tendon rupture, especially in older adults and those on steroids. Learn who’s most at risk, what symptoms to watch for, and why these drugs should be a last resort.
More Detail
How TRIPS Treaty Obligations Limit Access to Generic Medicines
Martyn F. Dec. 22 12The TRIPS Agreement enforces strict pharmaceutical patents that block affordable generic medicines in low-income countries. Despite legal flexibilities, political pressure and complex rules make access nearly impossible - leaving billions without life-saving drugs.
More Detail
Litigation in Generic Pharmaceutical Markets: How Patent Disputes Delay Affordable Medicines
Martyn F. Dec. 18 9Patent litigation in the generic drug market is delaying affordable medicines by years. Learn how Orange Book listings, serial lawsuits, and pay-for-delay settlements are shaping access-and what’s being done to fix it.
More Detail
Complex Generic Formulations: Why Proving Bioequivalence Is So Hard
Martyn F. Dec. 17 10Proving bioequivalence for complex generic drugs - like inhalers, creams, and injectables - is far harder than for simple pills. Learn why traditional testing fails, how manufacturers reverse-engineer secret formulas, and what’s being done to bring affordable alternatives to market.
More Detail
Licensed Pharmacies: How to Verify Your Pharmacy Is Legitimate and Avoid Counterfeit Drugs
Martyn F. Dec. 15 14Learn how to verify if your pharmacy is licensed and avoid counterfeit drugs. Follow simple steps to check state licenses, VIPPS accreditation, and real pharmacist access-before you buy.
More Detail